# Black Diamond Therapeutics, Inc.: Form DEF 14A, filed Apr 18, 2025

- Company: [Black Diamond Therapeutics, Inc.](/companies/bdtx.md) (CIK 1701541)
- Form: DEF 14A
- Filed: 2025-04-18
- Accepted by EDGAR: Apr 18, 2025, 16:01 ET
- Period: 2025-06-12
- Accession: 0001104659-25-036339
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1701541/000110465925036339/tm252436-4_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1701541/000110465925036339/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1701541/000110465925036339/tm252436-4_def14a.htm

Filed Apr 18, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-036339. Last ingested by Listed: Nov 10, 2026, 16:37 ET. No prices; not investment advice.